ETHINYL ESTRADIOL\NORELGESTROMIN: 6,648 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
6,648
Total FAERS Reports
12 (0.2%)
Deaths Reported
78
Hospitalizations
6,648
As Primary/Secondary Suspect
23
Life-Threatening
25
Disabilities
First Report: 19850924 · Latest Report: 20250820
What Are the Most Common ETHINYL ESTRADIOL\NORELGESTROMIN Side Effects?
#1 Most Reported
Product adhesion issue
3,932 reports (59.1%)
#2 Most Reported
No adverse event
3,014 reports (45.3%)
#3 Most Reported
Product quality issue
691 reports (10.4%)
All ETHINYL ESTRADIOL\NORELGESTROMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Product adhesion issue | 3,932 | 59.2% | 0 | 0 |
| No adverse event | 3,014 | 45.3% | 0 | 0 |
| Product quality issue | 691 | 10.4% | 0 | 5 |
| Inappropriate schedule of drug administration | 563 | 8.5% | 0 | 5 |
| Drug dose omission | 495 | 7.5% | 0 | 2 |
| Wrong technique in product usage process | 366 | 5.5% | 0 | 0 |
| Wrong technique in drug usage process | 349 | 5.3% | 0 | 0 |
| Product substitution issue | 269 | 4.1% | 0 | 0 |
| Off label use | 251 | 3.8% | 0 | 5 |
| Product use issue | 227 | 3.4% | 0 | 4 |
| Metrorrhagia | 220 | 3.3% | 0 | 0 |
| Application site pruritus | 215 | 3.2% | 0 | 0 |
| Application site rash | 163 | 2.5% | 0 | 2 |
| Application site erythema | 149 | 2.2% | 0 | 0 |
| Application site irritation | 139 | 2.1% | 0 | 0 |
| Vaginal haemorrhage | 136 | 2.1% | 0 | 3 |
| Nausea | 115 | 1.7% | 0 | 4 |
| Application site pain | 100 | 1.5% | 0 | 0 |
| Headache | 89 | 1.3% | 0 | 3 |
| Drug ineffective | 74 | 1.1% | 0 | 2 |
Who Reports ETHINYL ESTRADIOL\NORELGESTROMIN Side Effects? Age & Gender Data
Gender: 99.8% female, 0.2% male. Average age: 26.4 years. Most reports from: US. View detailed demographics →
Is ETHINYL ESTRADIOL\NORELGESTROMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 2 | 0 | 0 |
| 2001 | 3 | 0 | 0 |
| 2002 | 3 | 0 | 0 |
| 2003 | 5 | 0 | 0 |
| 2004 | 4 | 0 | 0 |
| 2005 | 7 | 0 | 3 |
| 2006 | 10 | 0 | 1 |
| 2007 | 4 | 0 | 0 |
| 2008 | 8 | 1 | 3 |
| 2009 | 6 | 0 | 1 |
| 2010 | 6 | 0 | 0 |
| 2011 | 15 | 0 | 1 |
| 2012 | 133 | 1 | 2 |
| 2013 | 725 | 0 | 6 |
| 2014 | 573 | 0 | 10 |
| 2015 | 209 | 0 | 6 |
| 2016 | 93 | 0 | 6 |
| 2017 | 74 | 0 | 6 |
| 2018 | 69 | 0 | 4 |
| 2019 | 93 | 0 | 6 |
| 2020 | 83 | 2 | 3 |
| 2021 | 682 | 0 | 1 |
| 2022 | 265 | 0 | 0 |
| 2023 | 448 | 0 | 0 |
| 2024 | 363 | 0 | 1 |
| 2025 | 79 | 0 | 0 |
What Is ETHINYL ESTRADIOL\NORELGESTROMIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 3,568 |
| Contraception | 2,489 |
| Menstruation irregular | 138 |
| Menstrual cycle management | 75 |
| Menstrual disorder | 59 |
| Dysmenorrhoea | 50 |
| Endometriosis | 34 |
| Menorrhagia | 27 |
| Hormone level abnormal | 26 |
| Ovarian cyst | 25 |
ETHINYL ESTRADIOL\NORELGESTROMIN vs Alternatives: Which Is Safer?
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHINYL ESTRADIOL\NORETHINDRONE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHINYL ESTRADIOL\NORGESTIMATE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHINYL ESTRADIOL\NORGESTREL
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHINYL ESTRADIOL\SEGESTERONE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHIODIZED OIL
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHIONAMIDE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHOSUXIMIDE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHYL ICOSAPENTATE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHYL LOFLAZEPATE
ETHINYL ESTRADIOL\NORELGESTROMIN vs ETHYLENE GLYCOL
Official FDA Label for ETHINYL ESTRADIOL\NORELGESTROMIN
Official prescribing information from the FDA-approved drug label.